Opthea Ltd
CYVNY- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815620
No open-market purchases or sales by Opthea Ltd insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCKDXF
13F holders, Q1 2022
Institutional positions in Opthea Ltd as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- −1 vs. Q4 2021
- Shares held
- 5.16M
- −481.9K (−8.5%) vs. Q4 2021
- Total value
- $33.7M
- −$8.73M (−20.6%) vs. Q4 2021
- New holders
- 1
- 1 more added
- Sold out
- 2
- 2 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CYVNY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 6 | $64.2K |
| Q2 2025 | 8 | $393.2K |
| Q1 2025 | 9 | $613.4K |
| Q4 2024 | 11 | $21.2M |
| Q3 2024 | 7 | $21.3M |
| Q2 2024 | 9 | $12.2M |
| Q1 2024 | 8 | $27.5M |
| Q4 2023 | 11 | $21.1M |
| Q3 2023 | 9 | $12.7M |
| Q2 2023 | 9 | $20.7M |
| Q1 2023 | 12 | $29.9M |
| Q4 2022 | 9 | $41.3M |
| Q3 2022 | 9 | $50.1M |
| Q2 2022 | 8 | $50.7M |
| Q1 2022 | 8 | $33.7M |
| Q4 2021 | 9 | $42.5M |
| Q3 2021 | 8 | $46.0M |
| Q2 2021 | 9 | $45.6M |
| Q1 2021 | 8 | $54.2M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Opthea Ltd; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 2,696,191 | $18.5M | 0.11% | −500,000−15.6% | Reduced |
| Victory Capital Management Inc | 1,596,207 | $9.82M | 0.01% | +21,513+1.4% | Added |
| Teacher Retirement System of Texas | 625,000 | $3.84M | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 170,246 | $1.11M | 0.00% | 00.0% | Unchanged |
| Bellevue Group AG | 48,000 | $313.0K | 0.00% | −1,000−2.0% | Reduced |
| Laurion Capital Management LP | 25,000 | $163.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7 | $0 | 0.00% | +7 | New |
| UBS Group AG | 0 | $0 | 0.00% | −1,915−100.0% | Sold out |
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −547−100.0% | Sold out |